SEC Form 4 research
| Issuer | Cogent Biosciences, Inc. |
|---|---|
| Tickers | UMRX, COGT, UNUM |
| Reporting owners | 37 |
| Officers and directors | 9 |
| Last public filing | 2026-10-05 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-05 | 2026-10-01 | Ferrante Karen Jean | A | 759 | $0 | Not reported |
| 2026-08-31 | 2026-08-27 | Morris Arlene | S | 3,161 | $37.54 | Not reported |
| 2026-08-31 | 2026-08-27 | Morris Arlene | S | 42,349 | $37.09 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.